Table 3. Biochemical Parameters at 0 and 3 Months in All Patients and in the H-ARB/CCB and M-ARB/CCB/HTCZ Groups.
All patients (n = 32) |
H-ARB/CCB (n = 20) |
M-ARB/CCB/HTCZ (n = 12) |
||||
---|---|---|---|---|---|---|
0 months | 3 months | 0 months | 3 months | 0 months | 3 months | |
BUN, mg/dL | 18 ± 11 | 20 ± 12 | 17 ± 12 | 21 ± 15 | 20 ± 7 | 19 ± 6 |
Cr, mg/dL | 0.9 ± 0.4 | 1.0 ± 0.4 | 0.9 ± 0.5 | 1.0 ± 0.4 | 1.0 ± 0.4 | 0.9 ± 0.4 |
eGFR, mL/min/1.73 m2 | 63 ± 21 | 61 ± 23 | 67 ± 22 | 63 ± 25 | 56 ± 18 | 60 ± 20 |
UA, mg/dL | 5.4 ± 1.3 | 6.0 ± 1.3* | 5.3 ± 1.2 | 6.0 ± 1.3* | 5.7 ± 1.4 | 6.2 ± 1.3 |
Na, mEq/L | 141 ± 2 | 140 ± 3 | 141 ± 2 | 140 ± 3 | 140 ± 2 | 140 ± 3 |
K, mEq/L | 4.0 ± 0.5 | 4.1 ± 0.7 | 4.0 ± 0.6 | 4.2 ± 0.7 | 4.0 ± 0.4 | 4.1 ± 0.6 |
TG, mg/dL | 145 ± 92 | 135 ± 72 | 138 ± 92 | 120 ± 61 | 155 ± 95 | 159 ± 84 |
LDL-C, mg/dL | 104 ± 32 | 102 ± 30 | 106 ± 35 | 104 ± 34 | 127 ± 46 | 129 ± 31 |
HDL-C, mg/dL | 52 ± 12 | 56 ± 16 | 51 ± 13 | 58 ± 18 | 52 ± 10 | 52 ± 10 |
FPG, mg/dL | 102 ± 229 | 116 ± 81 | 102 ± 35 | 122 ± 10 | 103 ± 16 | 106 ± 24 |
HbA1c, % | 5.3 ± 0.9 | 5.5 ± 0.8* | 5.4 ± 1.0 | 5.5 ± 1.0 | 5.2 ± 0.5 | 5.4 ± 0.5 |
BNP, pg/mL | 67 ± 92 | 55 ± 72 | 66 ± 70 | 66 ± 87 | 70 ± 124 | 36 ± 28 |
BUN: blood urea nitrogen; Cr: creatinine; eGFR: estimated glomerular filtration rate; UA: uric acid; Na: sodium; K: potassium; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; FPG: fast plasma glucose; HbA1c: hemoglobin A1c; BNP: brain natriuretic peptide. *P < 0.05 vs. 0 months.